ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,223Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 21

$865K Total Retail Price of All Prescriptions

Rank: 2 out of 21

554 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 554 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 554 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 12,972 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 728 595 1 2
LEVOTHYROXINE SODIUM 676 422 2 1
OMEPRAZOLE 597 472 3 4
POLYETHYLENE GLYCOL 3350 564 225 4 18
HYDROCODONE-ACETAMINOPHEN 560 464 S3 5 3
LISINOPRIL 526 410 6 7
AMLODIPINE BESYLATE 513 459 7 8
FUROSEMIDE 510 397 8 5
POTASSIUM CHLORIDE 418 348 9 6
WARFARIN SODIUM 377 374 10 9
CITALOPRAM HBR 323 216 11 12
METOCLOPRAMIDE HCL 295 108 12 61
GABAPENTIN 293 252 13 11
CARBAMAZEPINE 262 32 14 50
PREDNISONE 245 176 15 24
METOPROLOL SUCCINATE 216 189 16 20
DIGOXIN 216 190 16 29
LOSARTAN POTASSIUM 216 207 16 17
ATENOLOL 204 200 19 13
SINGULAIR 195 102 20 55
TRAMADOL HCL 188 176 21 16
HYDROCHLOROTHIAZIDE 176 128 22 14
METFORMIN HCL 171 116 23 10
LAMOTRIGINE 171 19 23 67
ZOLPIDEM TARTRATE 156 127 25 21
RISPERIDONE 155 89 26 46
LANTUS 145 136 27 34
CYMBALTA 142 124 28 30
MIRTAZAPINE 141 111 29 53
CARVEDILOL 139 106 30 26
RANITIDINE HCL 139 93 30 52
MELOXICAM 138 77 32 22
NOVOLOG 135 115 33 95
VENLAFAXINE HCL 135 121 33 72
LEVETIRACETAM 134 45 35 79
PANTOPRAZOLE SODIUM 133 95 36 31
MONTELUKAST SODIUM 124 63 37 85
AZITHROMYCIN 118 74 38 37
ATORVASTATIN CALCIUM 116 94 39 19
NEXIUM 106 14 40 25
GEMFIBROZIL 105 79 41 72
ALLOPURINOL 105 105 41 23
ALENDRONATE SODIUM 104 77 43 27
SERTRALINE HCL 100 64 44 35
QUETIAPINE FUMARATE 98 87 45 83
FENTANYL 94 53 S2 46 60
DOXYCYCLINE HYCLATE 93 63 47 71
CLONIDINE HCL 91 46 48 90
CLOPIDOGREL 89 72 49 46
CRESTOR 89 85 49 33
DIOVAN 89 89 49 66
METOPROLOL TARTRATE 88 68 52 15
DILTIAZEM 24HR CD 86 86 53 113
OXYCODONE-ACETAMINOPHEN 85 65 S2 54 115
DIVALPROEX SODIUM 84 44 55 62
LANSOPRAZOLE 80 67 56 118
DONEPEZIL HCL 78 78 57 32
OLANZAPINE 78 14 57 121
SELENIUM SULFIDE 76 0 59 122
PLAVIX 72 60 60 75
CIPROFLOXACIN HCL 71 59 61 40
LOSARTAN-HYDROCHLOROTHIAZIDE 70 70 62 78
GLYBURIDE 69 49 R 63 79
BACLOFEN 68 37 64 97
SUCRALFATE 68 49 64 74
FAMOTIDINE 68 26 64 62
LEVOFLOXACIN 67 28 67 58
CYCLOBENZAPRINE HCL 67 31 R 67 43
FENOFIBRATE 67 67 67 92
NAMENDA 67 67 67 28
CARAFATE 63 11 71 132
CEFTRIAXONE 63 28 71 132
SEROQUEL 61 49 73 136
TRAZODONE HCL 60 46 74 56
IBUPROFEN 60 35 74 103
ENDOCET 55 38 S2 76 148
VENLAFAXINE HCL ER 54 32 77 149
CARBIDOPA-LEVODOPA 54 42 77 68
HUMALOG 53 53 79 150
MUPIROCIN 52 12 80 104
PREMARIN 52 38 R 80 89
FINASTERIDE 52 52 80 153
SPIRIVA 51 45 83 75
PAROXETINE HCL 50 42 84 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.